CA2436943A1 - Composes d'hydantoine utiles en tant qu'agents anti-inflammatoires - Google Patents

Composes d'hydantoine utiles en tant qu'agents anti-inflammatoires Download PDF

Info

Publication number
CA2436943A1
CA2436943A1 CA002436943A CA2436943A CA2436943A1 CA 2436943 A1 CA2436943 A1 CA 2436943A1 CA 002436943 A CA002436943 A CA 002436943A CA 2436943 A CA2436943 A CA 2436943A CA 2436943 A1 CA2436943 A1 CA 2436943A1
Authority
CA
Canada
Prior art keywords
alkyl
substituted
ring
cyano
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002436943A
Other languages
English (en)
Inventor
Magali Jeannine Blandine Maillet
Eric Antoine Nicolai
Edwin J. Iwanowicz
Murali T.G. Dhar
Michele Launay
Dominique Potin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerep SA
Bristol Myers Squibb Pharma Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2001/045540 external-priority patent/WO2002044181A1/fr
Publication of CA2436943A1 publication Critical patent/CA2436943A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne des composés représentés par la formule (I): et des sels pharmaceutiquement acceptables de ceux-ci, utiles pour traiter des maladies inflammatoires ou immunes. Dans la formule, A représente un noyau saturé carbocyclique ou hétérocyclique comprenant de quatre à sept ramifications; L et K représentent O ou S; M représente N ou CH; Y représente N ou CH; Z représente hydrogène, alkyle ou alkyle substitué; et R1-R4 sont tels que définis dans la description.
CA002436943A 2000-12-01 2001-11-30 Composes d'hydantoine utiles en tant qu'agents anti-inflammatoires Abandoned CA2436943A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US25048600P 2000-12-01 2000-12-01
US25065300P 2000-12-01 2000-12-01
US60/250,653 2000-12-01
US60/250,486 2000-12-01
US72716501P 2001-02-28 2001-02-28
US60/727,165 2001-02-28
PCT/US2001/045540 WO2002044181A1 (fr) 2000-12-01 2001-11-30 Composes d'hydantoine utiles en tant qu'agents anti-inflammatoires

Publications (1)

Publication Number Publication Date
CA2436943A1 true CA2436943A1 (fr) 2003-06-06

Family

ID=28457726

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002436943A Abandoned CA2436943A1 (fr) 2000-12-01 2001-11-30 Composes d'hydantoine utiles en tant qu'agents anti-inflammatoires

Country Status (3)

Country Link
JP (1) JP2004519435A (fr)
CA (1) CA2436943A1 (fr)
HU (1) HUP0400531A3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501768B2 (en) * 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds

Also Published As

Publication number Publication date
JP2004519435A (ja) 2004-07-02
HUP0400531A2 (hu) 2004-06-28
HUP0400531A3 (en) 2006-05-29

Similar Documents

Publication Publication Date Title
US6710064B2 (en) Hydantoin compounds useful as anti-inflammatory agents
JP6924766B2 (ja) ベンゾピラゾール化合物及びその類似体
US6977267B2 (en) Spiro-hydantoin compounds useful as anti-inflammatory agents
EP2276756B1 (fr) Hydroxyméthyl pyrrolidines en tant qu`agonistes de récepteur bêta 3 adrénergique
AU2012320568B2 (en) Novel chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
JP3943394B2 (ja) αＬβ２介在細胞接着阻害剤
CA2724294A1 (fr) Antagonistes du recepteur de glucagon, compostions et procede d'utilisation de ces composes
JP2011529073A (ja) キナーゼ調節因子として有用な縮合ヘテロ環化合物
AU2009298617A1 (en) Spiro-imidazolone derivatives as glucagon receptor antagonists
AU2006259572A1 (en) Aspartyl protease inhibitors
EP2125819A2 (fr) Composés hétérocycliques fusionnés utiles en tant que modulateurs de kinases
MX2009001699A (es) IMIDAZOL AMINAS COMO INHIBIDORES DE LA ß-SECRETASA.
CA2499586A1 (fr) Inhibiteurs de la dipeptidyl peptidase heterocyclique beta-amino utiles pour le traitement ou la prevention du diabete
MX2008012860A (es) Desazapurinas de utilidad como inhibidores de janus cinasas.
CA3088548A1 (fr) Aminopyrrolotriazines en tant qu'inhibiteurs de kinase
CA3181793A1 (fr) Imidazopyrimidines en tant que modulateurs de l'il-17
US11993613B2 (en) Thiazolo[5,4-b]pyridine MALT-1 inhibitors
CA2436943A1 (fr) Composes d'hydantoine utiles en tant qu'agents anti-inflammatoires
CN113754635A (zh) 稠环类化合物及其制备方法和用途
AU2011236110B2 (en) Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
AU2002334771A1 (en) Spiro-hydantoin compounds useful as anti-inflammatory agents
MXPA06009929A (es) Heterociclos de nitrogeno biciclicos y en puente

Legal Events

Date Code Title Description
FZDE Discontinued